Publications
115 publications
Funding
12 grantsView NIH portfolio on RePORTER ↗
Active
5 grants- MPIP01AI202868-06Determinants of TB Control, Relapse, and ReinfectionNIAID · 2026–2031 · via NIH RePORTER
- MPIR01CA303125-01A1Hematopoietic stem cell encoded anti-tumor immunity: mechanisms and functionNCI · 2026–2031 · via NIH RePORTER
- PIR01AI064693-20A1Novel pathway of DNA inter-strand crosslink repair in mycobacteriaNIAID · 2005–2031 · via NIH RePORTER
- MPIR01AI196228-01Chalkophore mediated respiratory oxidase flexibility and M. tuberculosis virulenceNIAID · 2026–2029 · via NIH RePORTER
- KPU19AI162568-05S1Determinants of TB control, relapse and reinfection - Foreign Funding SupplementNational Institute of Allergy and Infectious Diseases · 2021–2026· 2 renewals
Completed grants (7)
- MPIP50CA221745-05RP-4: Immunologic Predictors of BCG Immunotherapy for Bladder CancerNCI · 2018–2025 · via NIH RePORTER
- PIR01AI138446-05Rip1 controlled stress resistance and virulence in Mycobacterium tuberculosisNIAID · 2019–2024 · via NIH RePORTER
- MPIU19AI111143-07Biomarkers of PZA activity and it's target populationsNIAID · 2014–2021 · via NIH RePORTER
- PIR01AI080619-05CD4 T Cell Responses to M. Tuberculosis InfectionNIAID · 2009–2015 · via NIH RePORTER
- PIR01AI053417-10Cyclopropane Synthetases and M.tuberculosis PathogenesisNIAID · 2003–2014 · via NIH RePORTER
- PIR01AI080628-02Molecular Analysis of the Rip1 Virulence Pathway of M. tuberculosisNIAID · 2009–2012 · via NIH RePORTER
Honors & distinctions
1 honor
- Damon Runyon Fellowship / Grant · Damon Runyon Cancer Research Foundation · 1995
News mentions
2 mentionsView all WCM news ↗
- New Insights into Bladder Cancer Treatment Could Help Improve ImmunotherapiesMay 29, 2025
Researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center are expanding the understanding of how the BCG treatment for early bladder cancer works.
- $5 Million NIH Center Grant Will Support Next Generation TB ResearchSeptember 7, 2022
Weill Cornell Medicine has been awarded a five-year, $5 million grant from the National Institutes of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to establish a new multi-institutional center for tuberculosis (TB) research and training the next generation of TB investigators.
Mentoring
6 menteesAll publications with mentees →
- AKAdam KrebsImmunology & Microbial Pathogenesis (PhD) · Class of 2024
- AAAnthony AntonelliImmunology & Microbial Pathogenesis (PhD) · Class of 2021
- OAOyindamola AdefisayoImmunology & Microbial Pathogenesis (PhD) · Class of 2021
- HBHitesh BhattaraiMolecular Biology (PhD) · Class of 2015
- SKShireen KhayatPharmacology (PhD)
- EBEmilee BarnardMolecular Biology (PhD)
External relationships
Ownership
Vedanta Biosciences
Advisory/Scientific Board Member
Burroughs Wellcome Fund · Institute for Research in Biomedicine Barcelona · Vedanta Biosciences